Regulation of immunosuppressive factors: OVs therapy can regulate the expression of immunosuppressive factors, such as inducing tumor cells to produce cytokines such as interferon, thereby downregulating the expression of PD-L1, enhancing the recognition and killing of tumor cells by immune cells, and improving the sensitivity of lung cancer to OVs therapy (39). The gene discussed is CD274; the disease is lung carcinoma.